Cargando…
Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis
AIM: IgA nephropathy (IgAN) is one of the leading causes of end-stage renal disease (ESRD). Urine testing is a non-invasive way to track the biomarkers used for measuring renal injury. This study aimed to analyse urinary complement proteins during IgAN progression using quantitative proteomics. METH...
Autores principales: | Niu, Xia, Zhang, Shuyu, Shao, Chen, Guo, Zhengguang, Wu, Jianqiang, Tao, Jianling, Zheng, Ke, Ye, Wenling, Cai, Guangyan, Sun, Wei, Li, Mingxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103701/ https://www.ncbi.nlm.nih.gov/pubmed/37065697 http://dx.doi.org/10.7717/peerj.15125 |
Ejemplares similares
-
Diagnostic Potential of Plasma IgA1 O-Glycans in Discriminating IgA Nephropathy From Other Glomerular Diseases and Healthy Participants
por: Zhang, Shuyu, et al.
Publicado: (2022) -
Urinary complement profile in IgA nephropathy and its correlation with the clinical and pathological characteristics
por: Wang, Dongqing, et al.
Publicado: (2023) -
Complement Activation Is Associated With Crescents in IgA Nephropathy
por: Wang, Zi, et al.
Publicado: (2021) -
Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA(1) Antibody in IgA Nephropathy Patients
por: Chiu, Yen-Ling, et al.
Publicado: (2021) -
The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy
por: Rizk, Dana V., et al.
Publicado: (2019)